A simple blood test to detect early signs of cancer. A noninvasive way to screen pregnancies for common genetic conditions. An app store for your genetic information. Illumina, a San Diego-based gene-sequencing hardware and software behemoth with a market capitalization of $22 billion, is working on all these initiatives—and more.
{iframe}http://www.fastcompany.com/3058032/meet-the-new-ceo-of-the-22-billion-genomics-company-youve-never-heard-of?utm_source=mailchimp&utm_medium=email&utm_campaign=fast-company-daily-newsletter&position=1&partner=newsletter&campaign_date=04272016{/iframe}